flavored vapes – Misryoum reports President Trump challenged FDA Commissioner Marty Makary’s approval pace for flavored nicotine products.
President Donald Trump’s frustration with the FDA’s pace on flavored nicotine products is now reverberating inside the administration, putting FDA Commissioner Marty Makary in a precarious position, according to Misryoum.
Misryoum reports that last weekend Trump “upbraided” Makary after discussions with advisers about whether the agency is moving fast enough to approve flavored vapes and nicotine products.. The political push matters because Trump has repeatedly framed vaping policy as an issue worth “saving,” including during his 2024 campaign.
In this context. the dispute is less about whether flavored vaping is on the agenda and more about how quickly the FDA can change course.. Misryoum says the president sought input tied to the importance of flavored vapes with younger MAGA voters. while advisers raised concerns that Makary was blocking the White House’s vaping agenda.
The tension is also rooted in Makary’s earlier approach to flavors that are viewed as potentially attractive to children.. Misryoum reports that he resisted approving certain fruit and menthol-style vape flavors associated with the Los Angeles manufacturer Glas. and that his rationale centered on public health risk.
Meanwhile, Misryoum reports that Makary discussed possible adjustments with Trump, including a pivot away from earlier anti-flavored vape positions.. However. Misryoum says it was not clear whether the commissioner ultimately changed course. leaving uncertainty about whether the administration’s priorities will translate into immediate regulatory action.
If Trump decides to replace Makary. it would fit a broader pattern of shakeups in senior roles across the federal government. Misryoum reports.. The potential fallout would also come as states continue to operate their own restrictions on flavored vape and tobacco products. even as the FDA sets the nationwide regulatory baseline.
At stake is the way federal agencies carry out presidential priorities: when political pressure collides with public health guardrails. leadership turnover can become a signal to the bureaucracy about what is negotiable and what is not.. That dynamic is now at the center of Misryoum’s reporting on the FDA commissioner’s “thin ice” status.
In the end, the flavored vape fight is a window into how the White House intends to navigate one of the country’s most contentious consumer-health debates, with regulatory timing and credibility likely to matter as much as the policy itself.